By Associated Press - Tuesday, April 20, 2021

AMSTERDAM (AP) - European regulator says benefits of Johnson & Johnson vaccine outweigh risks despite ’possible link” to rare blood clots.

Copyright © 2025 The Washington Times, LLC.

Please read our comment policy before commenting.